Jesse M.
Weiss

Recent representative matters include:

• Representation of Illumina in an administrative challenge brought by the Federal Trade Commission (FTC) concerning Illumina’s $8 billion acquisition of GRAIL, a healthcare company developing a cancer screening test for 50 cancer types. In September 2022, the FTC’s Chief Administrative Law Judge ruled in favor of Illumina and rejected the FTC’s challenge to the merger.

• Representation of Tesla in consolidated putative class action antitrust litigation alleging Tesla has monopolized access to parts and services needed to repair its vehicles, and that the company’s actions have resulted in delays and supracompetitive pricing for Tesla vehicle maintenance.

• Representation of Amgen in successfully defending against an FTC challenge to Amgen’s pending $27.8 billion acquisition of Horizon Therapeutics, the largest in Amgen’s history. In September 2023, Amgen secured a consent order that ended all litigation and cleared the path for the deal to close.

• Representation of Altra Industrial Motion Corp. on antitrust issues in connection with its $5 billion acquisition by Regal Rexnord Corporation.

• Representation of Atlas Air Worldwide Holdings on antitrust issues in connection with its $5.2 billion acquisition by an investor group led by funds managed by affiliates of Apollo Global Management.

• Representation of American Express (“AmEx”) in several antitrust litigations in the U.S. District Court for the Eastern District of New York. Mr. Weiss previously represented AmEx in a civil action brought by the Department of Justice and 17 state attorneys general. The case culminated in a nearly two‑month bench trial in 2014, which was followed by successful appeals in favor of AmEx in both the Second Circuit and the Supreme Court.
• Representation of Barrick Gold Corporation in connection with the formation of a joint venture with Newmont Mining Corporation to combine their respective mining operations, assets, reserves and talent in Nevada.
• Representation of Orbotech Ltd. in connection with its $3.4 billion acquisition by KLA-Tencor Corporation.
• Representation of AveXis, Inc. in connection with its $8.7 billion acquisition by Novartis AG.

• Representation of Alere Inc. in connection with its $8 billion sale to Abbott Laboratories.

• Representation of Cameron International Corporation in connection with its $15 billion acquisition by Schlumberger Limited.

• Representation of Delhaize Group in connection with its $29 billion merger with Royal Ahold N.V.

• Representation of H.J. Heinz Company and 3G Capital in connection with Heinz’s $60 billion merger with Kraft Foods Group to form The Kraft Heinz Company.

• Representation of RELX Group in connection with its acquisition of Aries Systems, its acquisition of Safe Banking Systems, its acquisition of ThreatMetrix, its acquisition of bepress, and its acquisition of Appriss’s Crash and Project business group.

Mr. Weiss was a contributing author of the Mergers and Acquisitions chapter of the American Bar Association’s eighth (2017) and ninth (2022) editions of Antitrust Law Developments and the Mergers and Acquisitions chapter of the Annual Review of Antitrust Law Developments from 2018 through 2022.

Mr. Weiss was born in New York City. He received a B.A. from the University of Maryland in 2003 and a J.D. magna cum laude from Georgetown University Law Center in 2008. He joined Cravath in 2008 and was elected of counsel in 2021. Mr. Weiss is admitted to practice before the U.S. District Courts for the Eastern District of New York and the Southern District of New York.